StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Benzthiazide

HCID 178944527
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
1794768-22-1
Standard-SMILES
NS(=O)(=O)c1cc2c(cc1Cl)NC(CSCc1ccccc1)=NS2(=O)=O
InChIKey
NDTSRXAMMQDVSW-UHFFFAOYSA-N
Summenformel
C15H14ClN3O4S3
Durchschnittliche Molmasse
431,9 g/mol

Überblick

Benzthiazide is 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema. It has a role as a diuretic and an antihypertensive agent. It is a sulfonamide and a benzothiadiazine.

Namen und Bezeichner

Bevorzugter Name
Benzthiazide
IUPAC
3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1λ6,2,4-benzothiadiazine-7-sulfonamide
Englischer Name
Diucen-d7
Summenformel
C15H14ClN3O4S3
Molmasse
431.93736

Namen und Synonyme

benzthiazide91-33-8BenzothiazideAquatagFovaneExnaDihydrexLemazideUreseFreeurilDiucenEdemex
Weitere Namen anzeigen
Diucen-d7Aquatag-d7Dihydrex-d7Benzthiazide-d7Benzothiazide-d7Hydrochlorothiazide Impurity 31-d7 (Benzthiazide-d7)3-[(Benzylthio-d7)Methyl]-6-chloro-2H-1,2,4- benzothiadiazine-7-sulfonaMide 1,1-Dioxide6-Chloro-3-[[(phenylMethyl-d7)thio]Methyl]-2H-1,2,4-benzothiadiazine-7-sulfonaMide 1,1-Dioxide
ExosaltProaquaDiuceneRegulonBenzotiazidaBenzthiazidumFouanePfizer 1393

Datenbank-Bezeichner

CAS
1794768-22-1
ChEMBL
CHEMBL1201039
ChEBI
CHEBI:3047
UNII
1TD8J48L61

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,7
Polarare Oberfläche (TPSA)
161 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
7
Frei drehbare Bindungen
5
Schwere Atome
26
Formalladung
0
Komplexität
739

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
LogP · 3 Einträge

log Kow = 1.31 at pH 6.5

1.7

1.73

OdorCHARACTERISTIC
Taste · 2 Einträge

BITTER TASTE

CHARACTERISTIC

Color/Form · 2 Einträge

Crystals from acetone.

FINE, WHITE, CRYSTALLINE POWDER

Solubility · 3 Einträge

PRACTICALLY INSOL IN WATER, SOL IN ALKALINE SOLN

FREELY SOL IN DIMETHYLFORMAMIDE; SLIGHTLY SOL IN ACETONE; PRACTICALLY INSOL IN ETHER & CHLOROFORM

1.29e-02 g/L

Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Thiazide Diuretics

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

DecompositionWhen heated to decomposition it emits very toxic fumes of sulfoxides, nitroxides, and /hydrogen chloride/.

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 91 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesSkin Sens. 1 (100%)

Sicherheit und Schutzausrüstung

Disposal Methods · 1 Eintrag

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxikologische Informationen

Interactions · 5 Einträge

Chemie und Industrie

Pharmakologische Informationen

Protein Binding30%
Pharmacodynamics · 1 Eintrag

Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na<sup>+</sup>/Cl<sup>-</sup> reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.

Mechanism of Action · 6 Einträge

As a diuretic, benzthiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like benzthiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of benzthiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.

...BENZOTHIADIIDIDES HAVE DIRECT EFFECT ON RENAL TUBULAR TRANSPORT OF SODIUM & CHLORIDE...INDEPENDENT OF ANY EFFECT ON CARBONIC ANHYDRASE. /THIAZIDE DIURETICS/

...BENEFICIAL EFFECTS /OF THIAZIDES/ APPEAR TO RESULT FROM ALTERED SODIUM BALANCE. ...INITIATION OF TREATMENT...CARDIAC OUTPUT IS DECR & BLOOD VOL... DIMINISHED. ...CHRONIC THERAPY CARDIAC OUTPUT RETURNS TO NORMAL, PERIPHERAL VASCULAR RESISTANCE FALLS &...SMALL REDN IN EXTRACELLULAR WATER & PLASMA VOL. /THIAZIDE DIURETICS/

/DOMINANT ACTION OF THIAZIDES IS TO INCR/ RENAL EXCRETION OF SODIUM & CHLORIDE & ACCOMPANYING VOL OF WATER. ...VIRTUALLY INDEPENDENT OF ACID-BASE BALANCE. ... EVOKE SIGNIFICANT AUGMENTATION OF POTASSIUM EXCRETION. THEY VARY WIDELY IN THEIR POTENCY AS INHIBITORS OF CARBONIC ANHYDRASE. /THIAZIDE DIURETICS/

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
EC Number
202-061-0
Melting Point · 4 Einträge

210-211

231 to 232 °C

Melting point also reported as 238 to 239 °C.

231.5 °C

Physical DescriptionSolid
Stability/Shelf LifeSTABLE IN BOTH LIGHT & AIR
Dissociation Constants6

MANY DIABETIC PATIENTS REGULATED BY CHLORPROPAMIDE OR OTHER SULFONYLUREAS EXHIBIT IMPAIRED DIABETIC CONTROL WHEN ANY THIAZIDE DIURETIC IS ADDED TO DRUG REGIMEN. /THIAZIDE DIURETICS/

CONCURRENT ADMIN OF THIAZIDE DIURETICS & MONOAMINE OXIDASE INHIBITORS MAY INCR HYPOTENSION. /THIAZIDE DIURETICS/

...HYPOKALEMIA MAY INTENSIFY ACTION OF NEUROMUSCULAR BLOCKING AGENTS. ... POTASSIUM-DEPLETING DIURETICS ARE KNOWN TO CAUSE HYPOKALEMIA & MAY ENHANCE THIS EFFECT. /DIURETICS/

...CARDIAC GLYCOSIDE & DIURETIC; DIURETIC-INDUCED HYPOKALEMIA POTENTIATES CARDIOTOXICITY OF GLYCOSIDE. /DIURETICS/

For more Interactions (Complete) data for BENZTHIAZIDE (21 total), please visit the HSDB record page.

Health Effects · 1 Eintrag

Using large amounts of these drugs can result in a condition known as amphetamine psychosis -- which can result in auditory, visual and tactile hallucinations, intense paranoia, irrational thoughts and beliefs, delusions, and mental confusion.

Exposure RoutesAbsorbed in the digestive tract.
Toxicity Summary · 1 Eintrag

As a diuretic, benzthiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like benzthiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of benzthiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle.

Signs and SymptomsSymptoms of overdose include nausea, vomiting, fatigue, urinary problems and drowsiness.
Human Toxicity Excerpts · 3 Einträge

ASYMPTOMATIC HYPERURICEMIA OCCURS FREQUENTLY DURING PROLONGED TREATMENT. ACUTE ATTACK OF GOUT MAY BE PPT IN PATIENTS WITH HISTORY OF GOUT OR IN THOSE WITH RENAL FAILURE, BUT IS OBSERVED ONLY RARELY IN PATIENTS WITHOUT THESE DISABILITIES.

ADVERSE EFFECTS...HYPERSENSITIVITY (...RASH, URTICARIA...FEVER, RESPIRATORY DISTRESS, ANAPHYLACTIC REACTIONS)...GLYCOSURIA...MUSCLE SPASM, WEAKNESS, RESTLESSNESS, BLURRED VISION, & HEMATURIA... /THIAZIDE DIURETICS/

May suppress lactation, but compatible /SRP: with breast feeding/. /Thiazide diuretics, from table/

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Antidote and Emergency TreatmentThiazide diuretic overdose should be treated by immediate evacuation of the stomach followed by supportive symptomatic treatment and monitoring of serum electrolyte concentrations and renal function. /Thiazide diuretic/
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Non-Human Toxicity Values · 5 Einträge

LD50 MOUSE ORAL GREATER THAN 5000 MG/KG

LD50 RAT ORAL GREATER THAN 10000 MG/KG

LD50 DOG ORAL GREATER THAN 5000 MG/KG

RABBIT INTRAVENOUS 410 MG/KG

For more Non-Human Toxicity Values (Complete) data for BENZTHIAZIDE (6 total), please visit the HSDB record page.

Regulatorische Informationen

FDA Requirements · 1 Eintrag

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

UNILATERAL RENAL INTRA-ARTERIAL INJECTION OF THIAZIDES PRODUCES A UNILATERAL DIURETIC RESPONSE, INDICATING A DIRECT RENAL ACTION. ...THIAZIDES...ACTIVELY SECRETED IN PROXIMAL TUBULE. ... DEPENDING ON THIAZIDE, ITS DOSAGE & SOLUTES MEASURED, ITS ACTION ON ELECTROLYTE TRANSPORT MAY OR MAY NOT BE BLOCKED. /THIAZIDE DIURETICS/

For more Mechanism of Action (Complete) data for BENZTHIAZIDE (11 total), please visit the HSDB record page.

Absorption, Distribution and Excretion · 6 Einträge

Absorbed in the digestive tract.

DIURESIS OCCURS WITHIN 2 HR & LASTS 12-18 HR.

THIAZIDES ARE ABSORBED FROM GI TRACT & OWE THEIR USEFULNESS LARGELY TO THEIR EFFECTIVENESS BY ORAL ROUTE. ABSORPTION IS RELATIVELY RAPID. MOST AGENTS SHOW DEMONSTRABLE DIURETIC EFFECT WITHIN HR AFTER ORAL ADMIN. /THIAZIDE DIURETICS/

IN GENERAL, THIAZIDES WITH RELATIVELY LONG DURATIONS OF ACTION SHOW PROPORTIONATELY HIGH DEGREE OF BINDING TO PLASMA PROTEINS & ARE REABSORBED BY RENAL TUBULES. ... DRUG PASSES READILY THROUGH PLACENTAL BARRIER TO FETUS. ALL THIAZIDES PROBABLY UNDERGO ACTIVE SECRETION IN PROXIMAL TUBULE. /THIAZIDE DIURETICS/

DISTRIBUTED IN EXTRACELLULAR SPACE & /CROSSES/ PLACENTA /& APPEARS IN CORD BLOOD/. ONSET OF DIURETIC ACTION...2 HR...PEAK EFFECT...3 TO 6 HR...APPROX DURATION OF /ACTION OF SINGLE DOSE 12-18 HR/. EXCRETED BY GLOMERULAR FILTRATION & ACTIVE SECRETION IN PROXIMAL TUBULE /HUMAN, ORAL/.

ONSET OF HYPOTENSIVE ACTION...3 TO 4 DAYS, &...ACTION DISSIPATES...1ST WK AFTER DISCONTINUING CHRONIC THERAPY. /APPEARS/ IN MILK OF NURSING MOTHERS /HUMAN, ORAL/.

Cellular LocationsCytoplasm

Verwendung und Herstellung

Uses · 3 Einträge

THERAP CAT: Diuretic, antihypertensive.

MEDICATION

For the treatment of high blood pressure and management of edema.

Methods of Manufacturing · 2 Einträge

4-AMINO-6-CHLORO-M-BENZENEDISULFONAMIDE IS REACTED WITH CHLOROACETIC ANHYDRIDE TO GIVE 2,3'-DICHLORO-4',6'-DISULFAMOYLACETANILIDE WHICH IS THEN CAUSED TO CONDENSE & CYCLIZE BY TREATMENT WITH BENZYL MERCAPTAN IN PRESENCE OF SODIUM HYDROXIDE. US PATENT 3,111,517.

Prepn: J.M. McManus et al., 136th Am Chem Soc Meet (Atlantic City, Sept 1959) Abstr of Papers, pp 13-O; W.M. McLamore, G.D. Laubach, Ger pat 1,137,740; eidem, U.S. pat 3,440,244 (1962, 1960 both to Pfizer).

Formulations/PreparationsDOSAGE FORMS- TABLETS NF: 50 MG.

Anwendungen

VerwendenLabelled Benzthiazide (B209925). Benzthiazide is a diuretic, antihypertensive agent.